Series C funding round for ImCheck Therapeutics raising $100M in June 2022
Series C funding round for ImCheck Therapeutics raising $100M in June 2022
| Investor | Firm Type |
|---|
| Partner |
|---|
Andera PartnersLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Foundation | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$182M
Top Valuation
-
ImCheck Therapeutics raised $100M in a Series C round.
The round was announced on 06/01/22.
The round was led by Andera Partners, Earlybird Venture Capital.